Fractyl Health (GUTS) Total Non-Current Liabilities (2023 - 2026)

Fractyl Health (GUTS) reported Total Non-Current Liabilities of $77.4 million for Q1 2026, up 2.24% year-on-year from $75.7 million in Q1 2025, and down 30.41% quarter-over-quarter from $111.3 million in Q4 2025.

Fractyl Health (GUTS) has 4 years of Total Non-Current Liabilities data on file, last reported at $77.4 million in Q1 2026.

  • For the quarter ending Q1 2026, Total Non-Current Liabilities rose 2.24% year-over-year to $77.4 million; the trailing twelve-month figure through Mar 2026 stood at $77.4 million (up 2.24% YoY), and the FY2025 full-year result was $111.3 million, up 41.48% from the prior year.
  • Total Non-Current Liabilities for Q1 2026 stood at $77.4 million, down from $111.3 million in the prior quarter.
  • Across five years, Total Non-Current Liabilities topped out at $304.6 million in Q3 2023 and bottomed at $74.7 million in Q2 2024.
  • A 4-year average of $107.3 million and a median of $78.8 million in 2024 frame the typical range for Total Non-Current Liabilities.
  • Across the five-year window, Total Non-Current Liabilities plunged 75.2% in 2024 and surged 54.5% in 2025, its largest moves.
  • Tracing GUTS's Total Non-Current Liabilities over 4 years: stood at $304.6 million in 2023, then plunged by 74.18% to $78.7 million in 2024, then surged by 41.48% to $111.3 million in 2025, then tumbled by 30.41% to $77.4 million in 2026.
  • According to Business Quant data, Total Non-Current Liabilities over the past three periods registered $77.4 million, $111.3 million, and $116.7 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Quantum Biopharma 1,638,563.89 Bn 1,638,563.89 Bn - 11.03 Mn
2 Alterity Therapeutics 767,934.24 Bn 767,934.20 Bn - 42,980.09
3 Legend Biotech 2,937.00 Bn 2,936.10 Bn 242.10 Mn 95.20 Mn
4 Nanobiotix 2,226.01 Bn 2,225.95 Bn - 110.28 Mn
5 Akari Therapeutics 2,169.69 Bn 2,169.69 Bn - -
6 Vertex Pharmaceuticals 110.41 Bn 103.16 Bn 2.59 Bn 5.87 Bn
7 Regeneron Pharmaceuticals 66.44 Bn 57.69 Bn 3.31 Bn 7.32 Bn
8 Evaxion A 65.44 Bn 65.42 Bn - -
9 Alnylam Pharmaceuticals 39.53 Bn 36.52 Bn 959.66 Mn 4.05 Bn
10 Fractyl Health 19.24 Mn 19.24 Mn - 77.44 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 77.44 Mn
Dec 31, 2025 111.28 Mn
Sep 30, 2025 116.70 Mn
Jun 30, 2025 79.38 Mn
Mar 31, 2025 75.75 Mn
Dec 31, 2024 78.66 Mn
Sep 30, 2024 75.53 Mn
Jun 30, 2024 74.72 Mn
Mar 31, 2024 79.01 Mn
Sep 30, 2023 304.58 Mn